Figure S1. Effect of GNB4 overexpression on cell growth of 182R-6 and TAMR-1 cell lines (no drug treatment). A and B, MTT assay was performed using 182R-6 (a) and TAMR-1 (b) cells stably expressing GFP or GNB4 as described in “Methods”, using fulvestrant- and tamoxifen-free medium. Asterisk indicates p < 0.05. (PPTX 42 kb
Figure S5. Overexpression of CYGB in p53-null H1299 cells suppressed GLUT1 and HXK2 expression in p5...
Differences in suppressive effects of mTORC1 and GSK-3 inhibitors on cell proliferation. Relative ce...
TAGLN expression and methylation status, and lymph node metastasis of breast cancer; Figure S2. Univ...
Figure S2. Knockdown of GNB4 in TAMR-1 and 182R-6 cells using siRNA. 182R-6 and TAMR-1 cells grown t...
Figure S4. siRNA-mediated knockdown of GNB4 in TAMR-1 and 182R-6 cells. A, 182R-6 and TAMR-1 cells g...
Figure S3. Knockdown of GNB4 using siRNA suppresses proliferation of parental S05 cells. S05 cells g...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
Figure S1. The content of ESA+/CD44+/CD24â cell population within mammosphere culture in MDA-MB-23...
Figure S1. CYGB expression and promoter methylation in breast cancer. (A) Analysis of CYGB mRNA expr...
Decreased proliferation of nuclear stained GFP-Sox2 reporter cells at 72 h of treatment. Percentage ...
XIST and GAPDH methylation status in BC. XIST and GAPDH methylation was quantified using methylColle...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...
Knockdown of GGCT upregulates p21WAF1/CIP1 and/or p16INK4A in various cancer cells. Expression level...
Figure S4. Genetic suppression of GSK3β expression decreases the sphere-forming potential of mesench...
Figure S5. Overexpression of CYGB in p53-null H1299 cells suppressed GLUT1 and HXK2 expression in p5...
Differences in suppressive effects of mTORC1 and GSK-3 inhibitors on cell proliferation. Relative ce...
TAGLN expression and methylation status, and lymph node metastasis of breast cancer; Figure S2. Univ...
Figure S2. Knockdown of GNB4 in TAMR-1 and 182R-6 cells using siRNA. 182R-6 and TAMR-1 cells grown t...
Figure S4. siRNA-mediated knockdown of GNB4 in TAMR-1 and 182R-6 cells. A, 182R-6 and TAMR-1 cells g...
Figure S3. Knockdown of GNB4 using siRNA suppresses proliferation of parental S05 cells. S05 cells g...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
Figure S1. The content of ESA+/CD44+/CD24â cell population within mammosphere culture in MDA-MB-23...
Figure S1. CYGB expression and promoter methylation in breast cancer. (A) Analysis of CYGB mRNA expr...
Decreased proliferation of nuclear stained GFP-Sox2 reporter cells at 72 h of treatment. Percentage ...
XIST and GAPDH methylation status in BC. XIST and GAPDH methylation was quantified using methylColle...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...
Knockdown of GGCT upregulates p21WAF1/CIP1 and/or p16INK4A in various cancer cells. Expression level...
Figure S4. Genetic suppression of GSK3β expression decreases the sphere-forming potential of mesench...
Figure S5. Overexpression of CYGB in p53-null H1299 cells suppressed GLUT1 and HXK2 expression in p5...
Differences in suppressive effects of mTORC1 and GSK-3 inhibitors on cell proliferation. Relative ce...
TAGLN expression and methylation status, and lymph node metastasis of breast cancer; Figure S2. Univ...